Chemotherapy News and Research

Latest Chemotherapy News and Research

Experts provide first framework for treating hypercalcemia of malignancy in adults

Experts provide first framework for treating hypercalcemia of malignancy in adults

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

New method combines injectable radioactive gel with systemic chemotherapy to treat pancreatic cancer

IU researchers uncover new ways to prevent serious side effects for breast cancer patients

IU researchers uncover new ways to prevent serious side effects for breast cancer patients

Rising Medicare costs linked to increased use of new prostate cancer therapies

Rising Medicare costs linked to increased use of new prostate cancer therapies

Analysis finds more than 100 new genetic risk factors strongly linked to colorectal cancer

Analysis finds more than 100 new genetic risk factors strongly linked to colorectal cancer

Novel approach could pave the way for new treatments to prevent relapse in breast cancer patients

Novel approach could pave the way for new treatments to prevent relapse in breast cancer patients

User-friendly complete system for more targeted, effective thermal ablation of tumors

User-friendly complete system for more targeted, effective thermal ablation of tumors

New combination of drugs may lead to improved treatment of cervical cancer

New combination of drugs may lead to improved treatment of cervical cancer

CU study proves effectiveness of new multidrug treatment for patients with stage IV melanoma

CU study proves effectiveness of new multidrug treatment for patients with stage IV melanoma

Study reveals subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma

Study reveals subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma

Researchers discover how certain breast cancers persist after chemo and do not respond to immunotherapies

Researchers discover how certain breast cancers persist after chemo and do not respond to immunotherapies

Radical project aims to develop a new method for commercial production of anti-microbial peptides

Radical project aims to develop a new method for commercial production of anti-microbial peptides

Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

What Germany’s coal miners can teach America about medical debt

What Germany’s coal miners can teach America about medical debt

Water enriched with hydrogen molecules improves symptomatology of neuropathic pain in animal models

Water enriched with hydrogen molecules improves symptomatology of neuropathic pain in animal models

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Simplified treatment regimen results in dramatic decrease in early deaths from acute promyelocytic leukemia

Simplified treatment regimen results in dramatic decrease in early deaths from acute promyelocytic leukemia

GOSH delivers world-first base-edited cell therapy for a patient with relapsed T cell leukemia

GOSH delivers world-first base-edited cell therapy for a patient with relapsed T cell leukemia

Extra year of chemotherapy lowers the risk of cancer recurrence in children with Ikaros leukemia

Extra year of chemotherapy lowers the risk of cancer recurrence in children with Ikaros leukemia

Discovery of cellular uptake pathway for larger molecules can be harnessed to create new drugs

Discovery of cellular uptake pathway for larger molecules can be harnessed to create new drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.